InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
5,457.64
(
-0.03%
)
US TECH 100
18,614.00
(
0.51%
)
Dow Jones
40,444.92
(
-0.36%
)
Brent Oil
78.92
(
-2.06%
)
Bitcoin
67,905.53
(
0.19%
)
Post# of 427308
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Keep Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

ziploc_1

Send PM Follow Ignore
Followers 62
Posts 7582
Boards Moderated 1
Alias Born 01/02/2003

ziploc_1

Re: None

Monday, 09/12/2022 7:53:04 PM

Monday, September 12, 2022 7:53:04 PM

Post# of 427308
Perhaps my most important consideration for supporting Amarin to be under the aegis of a BP...is that Vascepa is a potentially powerful drug for many conditions, other than just CVD...and Amarin, after the decision of the ninth circuit, has been deprived of enough cash to properly pursue the R&D for these indications.
Public Reply Private Reply New Post
Keep Last Read
Keep Last Read Next 10 Report Keyboard Shortcuts
Next 10 Prev Next
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Detailed Quote
Recent AMRN News
More AMRN News
InvestorsHub NewsWire

FEATURED Cannabix Technologies to Deliver Innovative Breath Logix Alcohol Screening Device to Texas, USA • Jul 29, 2024 9:07 AM

INDEXR AI Merges With Moon Equity Holdings Corp. (MONI), Creating a Leading-edge Technology Company • MONI • Jul 29, 2024 9:59 AM

BNCM AND DELEX UNVEIL POST-MERGER MANAGEMENT PLANS • BNCM • Jul 29, 2024 9:00 AM

Glidelogic Corp. Announces Revolutionary AI-Generated Content Copyright Protection Solution • GDLG • Jul 26, 2024 12:30 PM

Southern Silver Files NI43-101 Technical Report for its Updated Preliminary Economic Assessment for the Cerro Las Minitas Project • SSV • Jul 25, 2024 8:00 AM

Greenlite Ventures Completes Agreement with No Limit Technology • GRNL • Jul 19, 2024 10:00 AM

Start posting your company's news
Only $200 per official company press release!